LTGO

13.0001.81%
NK

Neha Krishnamohan

Chief Business Officer & CFO

Ms. Neha Krishnamohan was Director of Latigo Biotherapeutics, Inc. from 2025 to February 2026 and serves as its CFO & Chief Business Officer since February 02, 2026. She had been Chief Financial Officer and Executive Vice President of Corporate Development at Artiva Biotherapeutics, Inc. since April 2024 until December 31, 2025. She served as Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Corporate Development at Kinnate Biopharma Inc. from June 7, 2021 to April 3, 2024. She serves as Independent Director at Arcutis Biotherapeutics, Inc. since September 2022. Ms. Krishnamohan has experience in healthcare investment banking and finance. Ms. Krishnamohan, was with Goldman Sachs from July 2008 to May 2021. She most recently served as a vice president in the Healthcare Investment Banking Group from January 2015 to May 2021 and was an Associate in the Healthcare Investment Banking Group from August 2011 to December 2014 and member of the Mergers and Acquisitions (M&A) Group within the Investment Banking Division. While at Goldman Sachs, she established herself as a senior leader in the healthcare coverage group, working with a variety of biopharmaceutical boards and management teams on a broad range of strategic financial matters, executing financings as well as leading M&A transactions. She holds a BSE in Biomedical Engineering and Economics from Duke University.

Positions